Clinical Trial

Infection Risk Associated With Digestive MDRO Carriage in Hospitalized Patients

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 12, 2026 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to evaluate the impact of digestive carriage of multidrug-resistant organisms (MDRO) on the risk of healthcare-associated infections in hospitalized adult patients. Patients will be screened at admission, weekly, and at discharge, with a 30-day post-discharge follow-up. The findings will support infection prevention and control strategies in Romanian hospitals.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-13.
Status change: Not Yet Recruiting → Recruiting 2026-03-11
Trial Details
NCT Number NCT07134270
Lead Sponsor Valeriu Gheorghita
Conditions Multi Drug Resistant Organisms
Enrollment 400 participants
Start Date 2026-01-01
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-12